| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Shemesh Shay | Chief Dev. & Ops. Officer | C/O NUVECTIS PHARMA, INC., 1 BRIDGE PLAZA, SUITE 275, FORT LEE | /s/ Shay Shemesh | 09 Jan 2026 | 0001896056 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVCT | Common Stock | Award | $0 | +150,000 | +9.1% | $0.000000 | 1,793,068 | 06 Jan 2026 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The 150,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Shemesh's continued service on such dates. |
| F2 | Includes shares of restricted common stock. |